Silvia Bio announced a GBP 3 million seed investment led by Northern Gritstone on 15 October 2026. The University of Sheffield spinout develops tools to identify why cells underperform when manufacturing complex biological medicines. Its platform combines cell profiling with practical interventions intended for existing production processes. Co-founders include Ed Curry, Melinda Pohle, Professor Adam Brown and Professor David James. The company plans to use the capital to automate its technology, expand its team and establish laboratory capacity at Sheffield's Innovation Centre. Its work targets manufacturing bottlenecks, rather than claiming a newly approved medicine or a demonstrated clinical treatment.
Silvia Bio raises GBP 3m to improve biologic manufacturing
Northern Gritstone leads seed backing for the Sheffield spinout

Keep reading
More Funding

BrightAI secures USD 97 million to scale physical AI infrastructure
Smith Point Capital led the investment in sensor based monitoring for essential services.

Dcubed raises EUR 27.2 million to expand space hardware production
Warsaw Equity Group led the oversubscribed Series A plus round for the German manufacturer.

Linq raises USD 90 million to expand AI powered mobile infrastructure
Andreessen Horowitz led the Series B and partner Ben Horowitz joined the board.


